Post-earnings recap
Reported
Thu, Nov 9, 2017
EPS actual
$1.12
EPS est.
$0.93
EPS surprise
+20.89%
1-day move
-0.66%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AstraZeneca reported an EPS of $1.12, exceeding expectations by 20.89%. However, the stock reacted negatively, declining by 0.66%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.12 | N/A | +20.89% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.